
    
      Female participants randomized in one of the cenerimod or placebo groups will receive
      combined oral contraceptives on Day 1 (i.e., prior to cenerimod or placebo administration,
      Period 1) and on Day 42 (i.e., 36 days after the stat of cenerimod or placebo, Period 2).

      Half of the participants randomized in one of the cenerimod or placebo groups will be
      enrolled in an accelerated elimination procedure part (Period 3).
    
  